These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4444092)

  • 21. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
    Nitti V
    Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
    [No Abstract]   [Full Text] [Related]  

  • 23. [Results of short course anti-tuberculous treatment (author's transl)].
    Yáñez A; Valenzuela P
    Rev Med Chil; 1981 Jul; 109(7):695-9. PubMed ID: 7330548
    [No Abstract]   [Full Text] [Related]  

  • 24. [Aggravation and relapse of tuberculosis before and after the clinical application of rifampicin (author's transl)].
    Shimizu T
    Kekkaku; 1976 Dec; 51(12):507-8. PubMed ID: 1018407
    [No Abstract]   [Full Text] [Related]  

  • 25. [A clinical trial of short-course chemotherapy for pulmonary tuberculosis patients (author's transl)].
    Kameda K; Kino C
    Kekkaku; 1974 Nov; 49(11):387-91. PubMed ID: 4455991
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical results of retreatment using rifampicin for more than 12 months for pulmonary tuberculosis (author's transl)].
    Urakami E; Nagasawa S
    Kekkaku; 1973 Sep; 48(9):411-6. PubMed ID: 4772413
    [No Abstract]   [Full Text] [Related]  

  • 27. Ambulatory intermittent rifampicin and ethambutol in the retreatment of pulmonary tuberculosis.
    Sriyabhaya N; Jittinandana A; Kecharanantana P
    J Med Assoc Thai; 1974 Nov; 57(11):551-7. PubMed ID: 4452812
    [No Abstract]   [Full Text] [Related]  

  • 28. [Problems in treatment of pulmonary tuberculosis: in terms of bacteriologic relapse (author's transl)].
    Mochizuki K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Sep; 18(9):597-604. PubMed ID: 7289249
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative study of the treatment of pulmonary tuberculosis by a combination of rifampicin and isoniazid administered daily and twice weekly for a year].
    Decroix G; Kreis B; Sors C; Birenbaum J; Le Lirzin M; Canetti G
    Rev Tuberc Pneumol (Paris); 1971; 35(1):39-54. PubMed ID: 5559724
    [No Abstract]   [Full Text] [Related]  

  • 30. Intermittent rifampicin treatment of tuberculosis.
    Riska N; Mattson K
    Scand J Respir Dis Suppl; 1973; 84():140-4. PubMed ID: 4522069
    [No Abstract]   [Full Text] [Related]  

  • 31. [Controlled clinical trial on efficacy of 5-month regimens and whole course intermittent 6-month regimens in treating bacillary pulmonary tuberculosis].
    Chu N; Yan B; Zhu L
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):388-91. PubMed ID: 11326873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rifampicin in the intermittent treatment of experimental tuberculosis in mice].
    Lucchesi M; Matzeu M; Mancini P
    G Ital Mal Torace; 1971; 25(6):313-8. PubMed ID: 5005063
    [No Abstract]   [Full Text] [Related]  

  • 33. [The oral use of rifampicin in 10 cases of chronic pulmonary tuberculosis].
    Soregaroli E; Pozzi M
    G Ital Mal Torace; 1969; ():Suppl 2:14-6. PubMed ID: 5357134
    [No Abstract]   [Full Text] [Related]  

  • 34. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative efficacy of daily and intermittent chemotherapy with combinations of rifampicin and isoniazid in chronic murine tuberculosis, with particular reference to the prevention of relapses.
    Kradolfer F; Schnell R
    Arzneimittelforschung; 1973 Oct; 23(10):1465-6. PubMed ID: 4591315
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparison of the effects between combined chemotherapy with and without rifampicin in original and re-treatment of pllmonary tuberculosis, with special reference to the grade of improvement of chest x-ray findings (author's transl)].
    Yoshida F; Inoue M; Yoshimura M; Ogawa T; Yoshida R
    Kekkaku; 1976 Sep; 51(9):353-62. PubMed ID: 1003722
    [No Abstract]   [Full Text] [Related]  

  • 37. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of tuberculosis with a transient aggravation during initial phase of chemotherapy (author's transl)].
    Kishimoto H; Kawachi H; Shimokata K
    Kekkaku; 1982 Feb; 57(2):95-8. PubMed ID: 7069978
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of intermittent short-course chemotherapy under full-course supervision on the treatment of smear positive pulmonary tuberculosis].
    Yan S; Ye H; Lin S
    Zhonghua Jie He He Hu Xi Za Zhi; 1996 Apr; 19(2):104-6. PubMed ID: 9388851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
    Girling DJ
    Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.